Rheonix has won an administrative supplement to an existing SBIR grant to develop the Zika test using its CARD cartridge and Encompass Optimum platform.
NEW YORK (GenomeWeb) – Rheonix will soon begin a clinical trial for a microarray-based test for sexually transmitted infections with the aim of submitting the assay to the US Food and Drug Administration for clearance next year.
NEW YORK (GenomeWeb) – Rheonix today said it received a Small Business Innovation Research Phase I Fast-Track grant to complete the development of its fully automated self-confirming assay for the simultaneous detection of HIV/AIDS antibodies and viral RNA in a single specimen.
